Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 220 - файл

.pdf
Скачиваний:
0
Добавлен:
28.08.2026
Размер:
86 Мб
Скачать
References
https://t.me/medicina_free
199
tumor [99]. In certain circumstances, it may be justied to remove the tumor only and await fetal maturation, while in some cases, chemotherapy may even be given while awaiting pulmonary maturation [4, 100].
8.6 Prognosis
8.6.1 Maternal Outcome
In Barrett’s series in 1913, in which expectant tumor treatment was carried out, the maternal mortality was 18.4%, as against 2% in patients treated surgically [101]. Laparoscopy results in decreased length of hospital stay, less blood loss, and a lower incidence of postoperative complica­tions [102].
8.6.1.1 Continuation ofPregnancy
Several possible pathophysiologic mechanisms can interfere with the normal continuation of pregnancy. First, it is a hormonal inuence. The problem could arise if bilateral adnexectomy/ ovariectomy is performed. Fortunately, there are cases with further normal pregnancy after that procedure (see Sect. 8.5.4.2). Second, it obstructs labor or pregnancy with the tumor or uterus incarcerated in the pelvis. The third is a second­ary infection of primary ovarian pathology. Graefe stated that ovarian cysts produce abor­tions or premature labor in 14–20% of cases.
pregnancy does not improve the maternal prog-
nosis, and unilateral oophorectomy can be
employed [40].
8.6.2 Fetal Outcome
8.6.2.1 Fetal Morbidity
The laparoscopy and laparotomy do not differ
concerning the fetal outcome—fetal weight, ges-
tational age, growth restriction, infant survival,
and fetal malformations [65, 100, 103, 104].
Preterm labor is reduced with laparoscopy by
severalfold [6, 77, 87]. There is only one long-
term follow-up (1–8years) study, with 11 cases,
and no evidence of developmental or physical
abnormalities in children after acute but non-
obstetrical laparoscopic surgery during preg-
nancy [105].
8.6.2.2 Fetal Mortality
No signicant differences in fetal outcomes
exist between emergency laparotomy (fetal
mortality 18%) and scheduled laparotomy (fetal
mortality 23%) [9]. Non-emergent GLS adnexal
mass operations during the second trimester
were completed without fetal loss [106]. Fetal
loss is the same with laparoscopy and laparot-
omy [6, 87].
References
8.6.1.2 Malignant Tumors
In 21 reviewed cases by Jubb, the diagnosis was followed by immediate laparotomy and unilateral oophorectomy. Fourteen patients had no further treatment. In 33% of re-explored patients, no residual carcinoma was found. Unfortunately, there is no record of grading of the carcinoma, and follow-up was inadequate. Because of this, the gure for the 5-year survival rate of nearly 60% is unreliable [35]. Creasman et al. treated patients with stage IA ovarian carcinoma more radically with good results at 5 years. It would seem equally likely that the good survival rates reected early diagnosis at routine antenatal examinations of patients. The sacrice of the
1. Marino T, Craigo SD. Managing adnexal masses in pregnancy. Contemp Obstet Gyneol. 2000;45:130–43.
2. Leiserowitz G, Cress R, et al. Adnexal masses in pregnancy: how often are they malignant? Gynecol Oncol. 2006;101:315–21.
3. Zanetta G, Mariani E, Lissoni A, Ceruti P, Trio D, Strobelt N, etal. A prospective study of the role of ultrasound in the management of adnexal masses in pregnancy. BJOG. 2003;110(6):578–83.
4. Schemeler W, Jeffrey PF, et al. Adnexal masses in pregnancy: surgery compared with observation. Obstet Gynecol. 2005;105:1098–103.
5. Bromley B, Benacerraf B. Adnexal masses during pregnancy: accuracy of sonographic diagnosis and outcome. J Ultrasound Med. 1997;16:447–52.
6. Webb KE, Sakhel K, Chauhan SP, Abuhamad AZ.Adnexal mass during pregnancy: a review. Am J Perinatol. 2015;32:1010–6.
200
https://t.me/medicina_free
8 Complex Ovarian Mass
7. Borgfeldt C, Andolf E. Transvaginal sonographic ovarian ndings in a random sample of women 25–40 years old. Ultrasound Obstet Gynecol. 1999;13:345–50.
8. Castillo G, Alcázar JL, Jurado M.Natural history of sonographically detected simple unilocular adnexal cysts in asymptomatic postmenopausal women. Gynecol Oncol. 2004;92(3):965–9.
9. Whitecar S, Higby MK, et al. Adnexal masses in pregnancy: a review of 130 cases undergo­ing surgical management. Am J Obstet Gynecol. 1999;181:19–24.
10. Giuntoli RLI, Vang RS, Bristow RE.Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol. 2006;49(3):492–505.
11. Yen SL, Murk W, etal. Risk analysis of torsion and malignancy for adnexal masses during pregnancy. Fertil Steril. 2009;91:1895–902.
12. Aujang ER.Giant ovarian cyst and pregnancy. Case report and literature review. Ginecol Obstet Mex. 2011;79:235–8.
13. Suprasert S, Siriaunkgul S, et al. Ruptured mature cystic teratomas mimicking advanced stage ovarian cancer: a report of 2 cases study. J Med Assoc Thail. 2004;87:1522–5.
14. Cagino K, Li X, Thomas C, Delgado D, Christos P, Acholonu U. Surgical management of adnexal masses in pregnancy: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2021;28(6):1171–1182.e2.
15. Hermans DC, van der Putten HWHM, etal. Adnexal masses in pregnancy. Onkologie. 2003;26:167–72.
16. Agarwal N, Parul, Kriplani A, Bhatla N, Gupta A.Management and outcome of pregnancies com­plicated with adnexal masses. Arch Gynecol Obstet. 2003;267(3):148–52.
17. Platek CE, Goldberg GL, etal. The management of a persistent adnexal mass in pregnancy. Am J Obstet Gynecol. 1996;173:1236–40.
18. Sunoo CS, Terada KY, Kamemoto LE, Hale R.Adnexal masses in pregnancy: occurrence by eth­nic group. Obstet Gynecol. 1990;75:38–40.
19. Boulay E, etal. Ovarian cancer complicating preg­nancy. Obstet Gynecol Clin N Am. 1998;25:385–99.
20. Harlozinska JK, Rabczynski J, etal. Density distri­bution and antigenic characterization of cell subpop­ulations isolated from cystic uids of ovarian serous neoplasms. Anticancer Res. 1989;9:161–6.
21. Platek D, Henderson C, Goldberg G.The manage­ment of a persistent adnexal mass in pregnancy. Am J Obstet Gynecol. 1995;173(4):1236–40.
22. Glanc P, Salem S, Farine D.Adnexal masses in the pregnant patient a diagnostic and management chal­lenge. Ultras Q. 2008;24(4):225–40.
23. Capone A. Ovarian cysts complicating pregnancy. Am J Surg. 1943;61:387–93.
24. Gofnet F.Ovarian cysts and pregnancy. J Gynecol Obstet Biol Reprod (Paris). 2001;30:S100–8.
25. McKerron RG.Pregnancy, labour and child-bed with ovarian tumour. London: Rebman Limited; 1903.
26. Hill DJ, Nowak A, Tush B, etal. The role of ultra­sonography in the detection and management of adnexal masses during the second and third tri­mesters of pregnancy. Am J Obstet Gynecol. 1998;179:703–7.
27. Yazbek R, Woelfer B, et al. The value of ultra­sound visualization of the ovaries during the routine 11–14 weeks nuchal translucency scan. Eur J Obstet Gynecol Reprod Biol. 2007;132:154–8.
28. Huang PH, Tsai KB, Tsai EM, Su JH.Hemorrhagic corpus luteum cyst torsion in term pregnancy: a case report. Kaohsiung J Med Sci. 2003;19(2):75–8.
29. Bider S, Dulitzky M, et al. Clinical, surgical and pathologic ndings of adnexal torsion in pregnant and nonpregnant women. Surg Gynecol Obstet. 1991;173:363–6.
30. Hibbard L. Corpus luteum surgery. Am J Obstet Gynecol. 1979;135:666–70.
31. Hallatt JG, Steele CH, Snyder M.Ruptured corpus luteum with hemoperitoneum: a study of 173 surgi­cal cases. Am J Obstet Gynecol. 1984;149(1):5–9.
32. Bernhard LM, Klebba PK, Gray DL, Mutch DG.Predictors of persistence of adnexal masses in pregnancy. Obstet Gynaecol. 1999;93:585–9.
33. Peterson EC, Edmunds FT, et al. Benign cystic teratomas of the ovary; a clinico-statistical study of 1,007 cases with a review of the literature. Am J Obstet Gynecol. 1955;70:368–82.
34. Comerci JT, Licciardi F, Bergh PA, Gregori C, Breen JL. Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature. Obstet Gynecol. 1994;84:22–8.
35. Jubb E. Primary carcinoma in pregnancy. Am J Obstet Gynecol. 1963;85:345–54.
36. Palmer J, Vatish M, Tidy J.Epithelial ovarian cancer in pregnancy: a review of the literature. BJOG Int J Obstet Gynaecol. 2009;116:480–91.
37. Novak ER, Lambrou CD, Woodruff JD. Ovarian tumors in pregnancy. An ovarian tumor registry review. Obstet Gynecol. 1975;46(4):401–6.
38. Beischer BW, Fortune DW, etal. Growth and malig­nancy of ovarian tumours in pregnancy. Aust N Z J Obstet Gynaecol. 1971;11:208–20.
39. Dobashi M, Isonishi S, Morikawa A, Takahashi K, Ueda K, Umezawa S, etal. Ovarian cancer compli­cated by pregnancy: analysis of 10 cases. Oncol Lett. 2012;3(3):577–80.
40. Creasman F, Smith JP, et al. Carcinoma of the ovary associated with pregnancy. Obstet Gynecol. 1971;38:111–6.
41. Sherard CA, Williams HJ, et al. Adnexal masses and pregnancy: a 12-year experience. Am J Obstet Gynecol. 2003;189:358–63.
42. Matsumoto A, Ito T, Hamaguchi F, Kasuga M, Mikami T, Hino M, et al. Primary and recurrent serous borderline tumors during pregnancy: a case report and literature review. Int Cancer Conf J. 2021;10(3):160–9.
43. Behtash N, Karimi Zarchi M, Modares Gilani M, Ghaemmaghami F, Mousavi A, Ghotbizadeh
References
https://t.me/medicina_free
201
F. Ovarian carcinoma associated with pregnancy: a clinicopathologic analysis of 23 cases and review of the literature. BMC Pregnan Childbirth. 2008;8:3.
44. Miyakoshi M, Gabionza D, etal. Decidualized ovar­ian endometriosis mimicking malignancy. Am J Roentgenol. 1998;171:1625–6.
45. DePriest CP, et al. Ultrasound screening for the early detection of ovarian cancer. J Clin Oncol. 2003;21:194s–9s.
46. Caverly C. Ovarian cyst complicating pregnancy. Am J Obstet Gynecol. 1931;21:566–74.
47. Noreen S, Chaudhri R, Kahloon LE, etal. A large unilocular mucinous cystadenoma in third tri­mester of pregnancy. J Coll Physicians Surg Pak. 2011;21:426–8.
48. Machado F, Vegas C, Leon J, Perez A, Sanchez R, Parrilla JJ, etal. Ovarian cancer during pregnancy: analysis of 15 cases. Gynecol Oncol. 2007;105:446.
49. Hertzberg MA, Bowie JD, etal. Adnexal ring sign and hemoperitoneum caused by hemorrhagic ovar­ian cyst: pitfall in the sonographic diagnosis of ecto­pic pregnancy. Am J Radiol. 1999;173:1301–2.
50. Fiegler M, Kaminski K, Rudol G, et al. Clinical value of a single serum CA-125 level in women with symptoms of imminent abortion during the rst tri­mester of pregnancy. J Reprod Med. 2003;48:982–8.
51. He K, Kallner A, Blombäck M, etal. Increased con­centrations of lactate dehydrogenase in pregnancy with preeclampsia: a predictor for the birth of small­for- gestational-age infants. Gynecol Obstet Investig. 1995;39:234–8.
52. Niloff J, Knapp R, Schaetzl E, Reynolds C, Bast RJ. CA125 antigen levels in obstetric and gyneco­logic patients. Obstet Gynecol. 1984;64(5):703–7.
53. Spitzer M, Kaushal N, Benjamin F. Maternal CA-125 levels in pregnancy and the puerperium. J Reprod Med. 1998;4(4):387–92.
54. Szecsi PB, Andersen MR, Bjørngaard B, Hedengran KK, Stender S. Cancer antigen 125 after delivery in women with a normal pregnancy: a prospec­tive cohort study. Acta Obstet Gynecol Scand. 2014;93(12):1295–301.
55. Han A, Gziri MM, etal. Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review. BMC Med. 2012;10:86.
56. Bourdel N, Huchon C, Abdel Wahab C, Azaïs H, Bendifallah S, Bolze P, et al. Borderline ovar­ian tumors: guidelines from the French National College of Obstetricians and Gynecologists (CNGOF). Eur J Obstet Gynecol Reprod Biol. 2021;256:492–501.
57. Lerner IE, Federman A, Abramovich G, et al. Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system. Am J Obstet Gynecol. 1994;170:81–5.
58. Wheeler AC, etal. Complex adnexal mass in preg­nancy: predictive value of color Doppler sonogra­phy. J Ultrasound Med. 1997;16:425–8.
59. Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. Int J Obstet Gynecol. 2003;1(1 Suppl):135–66.
60. Yoffe N, Bronshtein M, Brandes J, Blumenfeld Z. Hemorrhagic ovarian cyst detection by trans­vaginal sonography: the great imitator. Gynecol Endocrinol. 1991;5(2):123–9.
61. Baltarowich OH, Kurtz AB, Pasto ME, Rifkin MD, Needleman L, Goldberg BB.The spectrum of sono­graphic ndings in hemorrhagic ovarian cysts. Am J Roentgenol. 1987;148(5):901–5.
62. Jain KA. Sonographic spectrum of hemorrhagic ovarian cysts. J Ultrasound Med. 2002;21(8):879–86.
63. Bree RL, Edwards M, Bohm-Velez M, Beyler S, Roberts J, Mendelson EB. Transvaginal sonogra­phy in the evaluation of normal early pregnancy: correlation with HCG level. Am J Roentgenol. 1989;153(1):75–9.
64. Barbieri E, Oneda S, et al. Decidualized ovarian endometriosis in pregnancy: a challenging diagnos­tic entity. Hum Reprod. 2009;24:1818–24.
65. Yuen AM, et al. Laparoscopic management of adnexal mass during pregnancy. Acta Obstet Gynecol Scand. 1997;76:173–6.
66. Mascilini F, Moruzzi C, Giansiracusa C, Guastaerro F, Savelli L, De Meis L, etal. Imaging in gyneco­logical disease (10): clinical and ultrasound charac­teristics of decidualized endometriomas surgically removed during pregnancy. Ultrasound Obstet Gynecol. 2014;44(3):354–60.
67. Ando T, Kato H, Kawaguchi M, Furui T, Morishige K, Hyodo F, et al. MR ndings for differentiating decidualized endometriomas from seromucinous borderline tumors of the ovary. Abdom Radiol. 2020;45(6):1783–9.
68. Hill CE, Lee RA, et al. Ovarian surgery in preg­nancy. Am J Obstet Gynecol. 1975;122:565–9.
69. Gustafson SH, Stout FE, etal. Ovarian tumors com­plicating pregnancy; a review of 45 surgically proved cases. Am J Obstet Gynecol. 1954;67:1210–23.
70. Hess LW, Peaceman A, O’Brien WF, Winkel CA, Cruikshank DP, Morrison JC.Adnexal mass occur­ring with intrauterine pregnancy: report of fty-four patients requiring laparotomy for denitive manage­ment. Am J Obstet Gynecol. 1988;158(5):1029–34.
71. Cohen-Herriou S, Lucot JP, et al. Management of ovarian cysts during pregnancy: Lille’s experi­ence and literature review. Gynecol Obstet Fertil. 2013;41:67–72.
72. Crispens MA.Borderline ovarian tumours: a review of the recent literature. Curr Opin Obstet Gynecol. 2003;15(1):39–43.
73. Timmerman P, Collins WP, et al. Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver vari­ability and experience. Ultrasound Obstet Gynecol. 1999;13:11–6.
74. Taylor TK, Walker W, etal. Decidualisation of ovar­ian endometriomas in pregnancy: a management
202
https://t.me/medicina_free
8 Complex Ovarian Mass
dilemma. A case report and review of the literature. Arch Gynecol Obstet. 2015;291:961–8.
75. Caspi A, Ben-Arie Z, Appelman Y, etal. Aspiration of simple pelvic cysts during pregnancy. Gynecol Obstet Investig. 2000;49(2):102–5.
76. Caspi Y, Lurie S, etal. Ultrasound-guided aspiration for pain relief generated by simple ovarian cysts. Gynecol Obstet Investig. 1993;35:121–2.
77. Koo YJ, Kim HJ, Lim KT, Lee IH, Lee KH, Shim JU, et al. Laparotomy versus laparoscopy for the treatment of adnexal masses during pregnancy. Aust N Z J Obstet Gynaecol. 2012;52:34.
78. Montes De Oca MK, Dotters-Katz SK, Kuller JA, Previs RA. Adnexal masses in pregnancy. Obstet Gynecol Surv. 2021;76(7):437–50.
79. Upadhyay A, Stanten S, Kazantsev G, Horoupian R, Stanten A.Laparoscopic management of a nonob­stetric emergency in the third trimester of pregnancy. Surg Endosc Other Interv Tech. 2007;21(8):1344–8.
80. Mandi R, Bhar D, etal. Successful vaginal delivery despite a huge ovarian mucinous cystadenoma com­plicating pregnancy: a case report. Iran J Med Sci. 2013;38:339–42.
81. Teng JY, Chang CK, etal. Comparison of laparos­copy and laparotomy in managing hemodynamically stable patients with ruptured corpus luteum with hemoperitoneum. J Am Assoc Gynecol Laparosc. 2003;10:474–7.
82. Yamada T, Okamoto Y, Kasamatsu H, Mori H. Intraoperative autologous blood transfusion for hemoperitoneum resulting from ectopic pregnancy or ovarian bleeding during laparoscopic surgery. J Soc Laparoendosc Surg. 2003;7(2):97–100.
83. Phupong V, Sueblinvong T, Triratanachat S.Ovarian teratoma with diffused peritoneal reactions mimick­ing advanced ovarian malignancy. Arch Gynecol Obstet. 2004;270(3):189–91.
84. Kocak B, Ozturk N, etal. Laparoscopic management of ovarian dermoid cysts: a review of 47 cases. Ann Saudi Med. 2004;24:357–60.
85. Clément D, Barranger E, Benchimol Y, Uzan S. Chemical peritonitis: a rare complication of an iatrogenic ovarian dermoid cyst rupture. Surg Endosc. 2003;17:658.
86. Shamshirsaz AA, Shamshirsaz AA, Vibhakar JL, Broadwell C, Van Voorhis BJ. Laparoscopic man­agement of chemical peritonitis caused by der­moid cyst spillage. J Soc Laparoendosc Surg. 2011;15(3):403–5.
87. Ye P, Zhao N, Shu J, Shen H, Wang Y, Chen L, etal. Laparoscopy versus open surgery for adnexal masses in pregnancy: a meta-analytic review. Arch Gynecol Obstet. 2019;299:625–34.
88. Eichelberger LA, Balthazar U, etal. Robotic resec­tion of adnexal masses during pregnancy. Am J Perinatol. 2013;30:371–5.
89. Scheib HH, Boruta DM, et al. Laparoendoscopic single-site surgery for management of adnexal masses in pregnancy: case series. J Minim Invasive Gynecol. 2013;20:701–7.
90. Dursun C, Cağlar M, etal. Laparoendoscopic single-
site surgery for acute adnexal pathology during pregnancy: preliminary experience. J Matern Fetal Neonatal Med. 2013;26:1282–96.
91. Pearl R, Richardson W, et al. Guidelines for diag­nosis, treatment, and use of laparoscopy for sur­gical problems during pregnancy. Surg Endosc. 2011;25:3479–92.
92. Nezhat C, Silfen SL, Fehnel SH, etal. Laparoscopic ovarian cystectomy during pregnancy. J Laparoendosc Surg. 1991;1:161–4.
93. Uccella S, Rosa M, Biletta E, Tinelli R, Zorzato PC, Botto-Poala C, etal. The case of a serous borderline ovarian tumor in a 15-year old pregnant adolescent: sonographic characteristics and surgical manage­ment. Am J Perinatol. 2020;37(S2):S61–5.
94. Pittaway DE, Takacs P, Bauguess P. Laparoscopic adnexectomy: a comparison with laparotomy. Am J Obstet Gynecol. 1994;171:385–91.
95. Dede M, Yenen M, Yilmaz A, Goktolga U, Baser İ. Treatment of incidental adnexal masses at cesarean section: a retrospective study. Int J Gynecol Cancer. 2007;17(2):339–41.
96. Ulker V, Gedikbasi A, Numanoglu C, Saygı S, Aslan H, Gulkilik A.Incidental adnexal masses at cesar­ean section and review of the literature. J Obstet Gynaecol Res. 2010;36(3):502–5.
97. Mathew SA, Jesrani SK, etal. Conservative manage­ment of twisted ischemic adnexa in early pregnancy. Ann Med Health Sci Res. 2015;5:142–4.
98. Lynch F. Fibroids and ovarian cysts complicating pregnancy. Cal West Med. 1931;35:415–20.
99. Usui R. A retrospective survey of clinical, patho­logical and prognostic features of adnexal masses operated during pregnancy. J Obstet Gynecol Res. 2008;26:89–93.
100. Lenglet H, Robishong B, etal. Laparoscopic man­agement of ovarian cyst in pregnancy. Gynecol Obstet Fertil. 2006;34:101–6.
101. Barrett C.Ovarian tumors complicating pregnancy, delivery, and the puerperium. Surg Gynecol Obstet. 1913;16:28.
102. Balthazar U, Steiner AZ, Boggess JF, Gehrig PA. Management of a persistent adnexal mass in pregnancy: what is the ideal surgical approach? J Minim Invasive Gynecol. 2011;18:720–5.
103. Soriano Y, Saidman D, et al. Laparoscopy versus laparotomy in the management of adnexal masses in pregnancy. Fertil Steril. 1999;71:955–60.
104. Mendilcioglu CG, Trak B, etal. Laparoscopic man­agement of adnexal masses. Safety and effective­ness. J Reprod Med. 2002;47:36–40.
105. Rizzo AG.Laparoscopic surgery in pregnancy: long­term follow-up. J Laparoendosc Adv Surg Tech A. 2003;13(1):11–5.
106. Akira S, Yamanaka A, Ishihara T, Takeshita T, Araki T. Gasless laparoscopic ovarian cystectomy dur­ing pregnancy: comparison with laparotomy. Am J Obstet Gynecol. 1999;180(3 Pt 1):554–7.
Ruptured Ectopic Pregnancy
https://t.me/medicina_free
9
Abstract
Ectopic pregnancy is one of the most com­mon nonsurgical abdominal conditions dur­ing pregnancy. Unfortunately, most of these presentations are during early pregnancy when the conceptus is not developed for independent life and is also not “viable.” Preoperative and early diagnosis is common due to the specic clinical presentation and the routine use of βHCG for women of reproductive age presenting with pain in the lower abdomen. Both conservative and operative interventions are available and successful depending on the fetal status and severity of bleeding. The biggest diagnostic and therapeutic dilemmas arise in patients with heterotopic or advanced abdominal pregnancies. The clinician should always look for intrauterine pregnancy preopera­tively, even when ectopic pregnancy is con­rmed. Advanced abdominal pregnancy poses a real intraoperative problem due to adherence of the placenta to surrounding organs and tissues, and insisting on its com­plete removal can cause signicant and sometimes unstoppable bleeding. Hepatic and splenic pregnancies are prone to severe bleeding due to the pronounced vascularity of these organs.
9.1 Ectopic Pregnancy
inGeneral
If a woman with a child be bled, she will have an abortion, and this will be more likely to happen the larger the fetus
(Hippocrates, 400)
If one is confronted with a pelvic condition that fol­lows no rules and conforms to no standards, he should think of ectopic pregnancy and pelvic tuberculosis.
(Howard Atwood Kelly)
9.1.1 Incidence
Ectopic pregnancy (EP) is the implantation of a fer­tilized egg outside the uterine endometrium. The rate of EP is constantly increasing. EPs quadrupled from 17,800in 1970 to 88,000in 1989 [1]. This is an increase from 4.5/1000 to 16.8/1000. In 1992, the USA EP rate was estimated at 1.97% of all preg­nancies [2] and was rising [3]. Further increase was during 2006–2013in the USA [4]. The prevalence of EP among women attending an emergency department with rst-trimester bleeding, pain, or both ranges from 6% to 16% [5]. An EP occurs with seasonal variation and is most common in June and December [6]. The reason is unclear, but the repro­duction is seasonal, depends on photoperiod and temperature, and varies with different latitudes.
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 G. Augustin, Acute Abdomen During Pregnancy, https://doi.org/10.1007/978-3-031-26021-6_9
203
204
https://t.me/medicina_free
9 Ruptured Ectopic Pregnancy
9.1.2 Risk Factors
If the egg is too big, or if the diameter of the tuba Fallopiana is too small, the egg stops and can get no farther but shoots forth and takes root there.
(Pierre Dionis, 1718)
The overall risk is approximately 1/200 preg­nancies, but may be increased 20- to 100-fold in specic subsets of women [6]. Risk factors are presented in Table9.1.
As many as 50% of Fallopian tubes removed because of an EP show prior inammatory disease.
Table 9.1 Risk factors for ectopic pregnancy [3, 7]
Pelvic inammatory disease Previous tubal (ectopic) pregnancy Current intrauterine device use Previous tubal surgery, including tubal sterilization Previous infertility treatments Endometriosis Emergency contraception
Spontaneous ectopic pregnancy
Post IVF-ET ectopic pregnancy
Although the risk of pregnancy is very low with a tubal ligation, if a pregnancy does occur, 10–50% are EP, representing a 20- to 100-fold increased risk [6]. Frequency is also higher with endometrio­sis, assisted reproductive technology (ART), and emergency contraception [7]. The pathogenesis of tubal pregnancy after natural and invitro fertiliza­tion (IVF) conception is presented in Fig.9.1.
9.1.3 Classication
9.1.3.1 Tubal Pregnancy
More than 95% of EPs implant the Fallopian tube. Pregnancies can grow in the mbrial end (11%), the ampulla (70%), the isthmus (12%), and the cornual and interstitial part of the tube (2%) [9]. The tubal EP results from embryo retention within the Fallopian tube due to impaired embryo-tubal transport and alterations in the tubal environment allowing early implantation [10].
Maternal age
Cigarette smoking
Previous ectopic pregnancy
Tubal factor infertility
Pelive inflammatory disease
Previous tubal surgery
Endometrisic
Risk factors
Tubal abnormality
Altered tubal
environment
Possible pathogenic mechanism involved
Ectopic pregnancy
Infertility history
Uterine abnormality
Impaired tubal transport
Impaired endometrial receptivity Increased uterine contractility
Embryo retention and implantation in the fallopian tube
Infertility treatment
Transfer technique
Hydrostatic pressure
Transfer fluid medium
Uterine contractility
Controlled ovarian
hyperstimulation
Altered hormone milieu
Tubal abnorality
Retrograde transport to fallopian tube
Uterine abnormality
Enhanced uterine contractility
Embryonic factors
Impaired
endometrial receptivity
blastocyst & receptive endometrium
Fig. 9.1 Potential mechanisms involved in the pathogenesis of tubal pregnancy after natural and IVF conception related to established risk factors. (Reproduced with permission from [8])
9.1 Ectopic Pregnancy inGeneral
https://t.me/medicina_free
205
9.1.3.2 Non-tubal Ectopic Pregnancy
Less than 5% of EPs occur in the ovary, cervix, or intra-abdominally, and the locations slightly dif­fer between normal conception and conception after ART (Fig.9.2) [9].
9.1.3.3 Heterotopic Pregnancy
Heterotopic pregnancy (HP) is the coexistence of intrauterine and extrauterine gestation. The inci­dence of HP has been reported as 1/8000– 1/30,000 in natural conception [12]. However, the rate is higher due to ART and is approxi­mately 1/7000 overall and as high as 1/900 with ovulation induction [13, 14]. The Fallopian tube is the most common location with HP.However, cervical and ovarian HPs have also been reported [15, 16]. Most reported HPs are singleton intra­uterine pregnancies. Triplet and quadruplet HPs are extremely rare [17, 18], frequently after ART.
9.1.3.4 Persistent Ectopic Pregnancy
A persistent EP refers to the continuation of tro­phoblastic growth after a surgical intervention to remove an EP. After a conservative procedure to preserve the affected Fallopian tube, such as a sal-
pingotomy, some trophoblastic tissue, perhaps deeply embedded, has escaped removal and con­tinues to grow, generating a new rise in βHCG lev­els [19]. After weeks, this may lead to new clinical symptoms, including bleeding. A less than 55% decline at day 3 predicts persistent EP and may select early cases for second-line methotrexate (MTX) therapy [20]. βHCG dynamics in the week before salpingotomy and bleeding activity at sur­gery may identify patients at risk of persistent EP after laparoscopic linear salpingotomy [19].
9.1.4 Clinical Presentation
Textbooks from the rst half of the twentieth cen­tury claimed that the diagnosis of EP was based on clinical criteria (gastric and mammary symp­toms of pregnancy, cessation of the menstrual cycle, palpation of a tumor near an enlarged uterus, ballottement in the tumor, and purple dis­coloration of the vagina) and had 20% false pre­operative diagnosis of a ruptured EP.In contrast, diagnosing an unruptured EP was virtually impossible [21].
Fig. 9.2 Sites and incidence of implantation in ectopic pregnancy following natural conception (left) and assisted reproductive technology (right). (Modied from [11])
206
https://t.me/medicina_free
9 Ruptured Ectopic Pregnancy
9.1.4.1 Medical History
The clinical features are complex and subject to signicant variations in character and severity. A quote from Howard A.Kelly seems timely that if
one is confronted with a pelvic condition that fol­lows no rules and conforms to no standards, he should think of ectopic pregnancy and pelvic tuberculosis [22]. The explanation of these dif-
culties lies in the fact that the symptoms associ­ated with extrauterine gestation arise not directly from the presence of the growing ovum in the Fallopian tube but from certain secondary lesions, either traumatic or inammatory, which super­vene. These secondary lesions may be briey enumerated as follows [23]:
• intraperitoneal ooding from tubal abortion or
rupture,
• intratubal bleeding leading to acute distension
of the tube, the abdominal ostium being
sealed,
• slowly progressive or recurrent bleeding lead-
ing to the formation of encysted collections of
blood (pelvic hematoma, in the broad liga-
ment, pelvic hematocele, in the pouch of
Douglas, peritubal hematocele, around the
abdominal end of the tube),
• infection of the gravid tube or an encysted col-
lection of blood leading to suppuration.
Until these secondary lesions, extrauterine pregnancy gives no more local or general distur­bance than an early pregnancy in the uterus. An important symptom associated with this phase, a brief period of amenorrhea, is the most helpful in diagnosis, but it is not always present. When a healthy adult woman, who is usually regular, goes for 2–3weeks over the expected date of her period, there is a “strong presumption of preg­nancy.” However, at this time, there is nothing to indicate whether the pregnancy is uterine or extrauterine. In the latter case, however, amenor­rhea is of very brief duration, seldom more than 7–8weeks, and then gives place to hemorrhage. In 30% of the cases, there is no amenorrhea at all. As it is quite unusual for an extrauterine gestation to continue undisturbed beyond the end of the second month, there is consequently no time for
the appearance of other general pregnancy symp­toms. However, occasionally, morning sickness and early breast changes may be present.
When the course of the gestation becomes interrupted by any of the occurrences mentioned above, the clinical features undergo rapid trans­formation, and symptoms of extrauterine preg­nancy appear—those that result from the interruption of the pregnancy by injury to the developing ovum or its containing sac. These symptoms, regarded as secondary symptoms, are highly variable in character and intensity in cor­respondence with the nature of the lesion which has given rise to them. The most easily recog­nized is intraperitoneal ooding; the symptoms that attend to it are uniform and characteristic. With a clinical history of amenorrhea and a care­ful pelvic examination made, mistakes are rare. Perforation of a hollow viscus, such as the stom­ach, duodenum, or gall bladder, is the only condi­tion for which it is likely to be mistaken, even under the circumstances unfavorable for diagno­sis. Constant bleeding from the uterus is a sec­ondary symptom of extrauterine gestation. If no period of amenorrhea has occurred, it forms the initial symptom, and if there has been amenor­rhea, it succeeds it. Mostly, it is the earliest indi­cation of anything wrong. However, as the same thing frequently occurs from the disturbance of a uterine pregnancy, little importance is usually given to it. The bleeding is slight or moderate in degree, sometimes continuous, sometimes irreg­ular; it is usually dark, thick, and syrupy in appearance. It may continue for several weeks if the patient is not relieved by the operation. The bleeding is due to separation and discharge of the uterine decidua, sometimes complete, more often in fragments. However, in most cases, the pieces of membrane do not attract attention. The most interesting phenomenon is this attempt on the uterus to throw off its decidua when the tubal ovum has been damaged. Some reex mecha­nism is initiated, which excites uterine contrac­tion insufciently powerful to detach portions of the membrane from the uterine wall and gives rise to bleeding, which continues until the whole decidua has been expelled. It is possible that at the commencement, some blood that escapes
9.1 Ectopic Pregnancy inGeneral
https://t.me/medicina_free
207
from the uterus may have made its way there from the gravid tube through the interstitial por­tion. In cases submitted to an operation, the hem­orrhage always ceases a few days after removing the tube. Retained portions of decidua give rise to persistent bleeding.
The effects produced by the rapid effusion of a large quantity of blood into the peritoneal cav­ity are, in the order of their occurrence, as follows [23]:
1. acute abdominal pain,
2. fainting and the constitutional signs of
bleeding,
3. shock, attended by vomiting and lasting for
several hours.
No matter the nature of the secondary lesions with tubal pregnancy, two symptoms are com­mon—uterine bleeding and pain. The pain has certain characteristics—sudden in onset, usually spontaneous, although muscular effort, such as lifting something heavy or the act of defecation, may appear to excite it. It is always severe and often most intense. First, it affects the whole abdomen. Later it may become localized. It is frequently attended with vomiting and signs of shock, sometimes with faintness or actual syn­cope; after lasting acutely for several hours, it subsides and may recur at varying intervals of a few days or a week until several attacks have been sustained; sometimes continuous pain with­out exacerbation follows the rst attack. The ini­tial pain attack is almost always due to bleeding; the subsequent attacks have a more complex ori­gin. However, pain bearing the broad characteris­tics described above is a constant symptom of extrauterine gestation. In cases not immediately submitted to an operation, recurrent attacks of intense pain may occur from repeated intraperito­neal hemorrhages. The classic signs of hemoperi­toneum except abdominal pain include shoulder pain caused by phrenic nerve irritation, an urge to defecate, and syncope, even in the absence of hypovolemia.
Rupture of ovarian pregnancy classically occurs during the rst trimester and is preceded by pain corresponding to distension of the ovar-
ian capsule. In developed countries, due to early diagnosis, only 8–21% of ovarian pregnancies are observed with hemodynamic shock [24].
For simultaneous intestinal obstruction with ectopic pregnancy, see Sect. 18.12.2. Subjective symptoms of pregnancy may also be present, such as breast tenderness and emesis gravidarum.
9.1.4.2 Physical Examination
Cullens sign (Fig. 9.3) is the bluish-black appearance around the umbilicus, unassociated with any history of injury, and a denite uterine history usually typical of the slow tubal abortion type of bleeding. Although Cullen rst described the sign in 1918 and labeled it a new sign in rup­tured extrauterine pregnancy [26], discoloration of the umbilicus due to peritoneal extravasations had been previously reported by Ransohoff in
1906. He described jaundice of the umbilicus in a patient with a ruptured common bile duct. In 1909, Hofstatter observed a blue discoloration of an umbilical hernia (Hofstatter’s sign) in a patient with a ruptured tubal gestation. However, the dis­coloration in Hofstatter’s case was not due to ecchymosis, but rather the transmission of the
Fig. 9.3 Cullens sign is a bluish-black appearance around the umbilicus; extension does not depend on the amount of bleeding but the duration of the primary pro­cess and other undetermined factors. (Reproduced with permission from [25])
208
https://t.me/medicina_free
9 Ruptured Ectopic Pregnancy
color of the blood through the thinned-out semi­transparent hernia.
Meyers etal., by computed tomography, rst noted that blood in the abdominal wall might be responsible for these signs [27]. They dened the anatomy of various retroperitoneal spaces and compartments, revealing a direct extension of hemorrhagic uid from the posterior parare­nal space to the lateral edge of the quadrates lumborum muscle, where a defect in the trans­versalis fascia permits access to the abdominal wall musculature. The intramuscular hemor­rhagic uid presumably reaches the subcutane­ous tissues via interruptions in muscular continuity. Cullen’s sign results from tracking blood along the round ligament to the umbili­cus. The portal of entry to the round ligament complex from the retroperitoneum is via the gastrohepatic ligament to the falciform liga­ment at the inferior-posterior liver edge [28]. The falciform ligament contributes to the con­nective tissue tube covering the round ligament (obliterated left umbilical vein) as it passes to the umbilicus.
The appearance of periumbilical ecchymosis is a rare and late manifestation of intraperito­neal bleeding. In Cullen’s case, the discolor­ation began 1 week after the onset of pain. Undoubtedly, prompt surgical treatment pre­vents the development of that sign in many cases. It is possible that in some cases, the sign appears after the operation without being observed preoperatively. One also wonders how many patients with tubal abortion, who undergo spontaneous resolution without operation, may develop the sign and never come under medical observation. The presence or degree of discolor­ation is not related to the amount of bleeding but rather to its duration and other undetermined factors (Table9.2).
Adnexal masses are often not palpable [29,
30], and tachycardia is not always present.
Atypical ndings include paradoxical bradycar­dia [31], fever [32], and uterine enlargement sug­gestive of an IUP [32]. Rectal bleeding is a sign of communication (inltration) between colorec­tum and EP (see Sect. 26.6).
Table 9.2 Conditions associated with non-iatrogenic Cullen’s sign
Acute pancreatitis Pancreatic trauma Ruptured ectopic pregnancy Ruptured aortic/iliac aneurysm Ruptured spleen Perirenal hematoma/bleeding Ruptured common bile duct Perforated duodenal ulcer Hepatocellular carcinoma Hepatic lymphoma Amebic liver abscess Metastatic thyroid cancer Rectus sheath hematoma
9.1.5 Dierential Diagnosis
Differential diagnosis of Cullen’s sign includes several conditions. Periumbilical cellulitis typi­cally causes blanching erythema that is warm to the touch. Sister Mary Joseph’s sign (nodule)—a metastatic spread of an intra-abdominal malig­nancy to the umbilicus—may present with thick­ening and erythema of periumbilical skin or as a palpable mass lesion around the umbilicus [33]. Subcutaneous administration of heparin may result in abdominal wall ecchymoses, which are typically distant from the umbilicus. Patients with psoriasis may develop periumbilical ery­thema with a silvery scale that bleeds on removal (Auspitz’s sign). Umbilical endometriosis is accompanied by bleeding in conjunction with the menstrual cycle. Ulceration of a recanalized umbilical vein in the setting of cirrhosis may cause periumbilical skin darkening [34].
Signs of intra-abdominal bleeding without
Cullen’s sign have various nontraumatic causes.
9.1.6 Diagnosis
HP can have various presentations. Before symp­toms, it is more likely: (1) with persistent or ris­ing β-human chorionic gonadotropin (βHCG) levels after dilatation and curettage for an induced/spontaneous abortion, (2) when the uter­ine fundus is larger than for menstrual dates, and